These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 17710597)
1. The impact of the cox-2 inhibitor issue on perceptions of the pharmaceutical industry: content analysis and communication implications. Lofstedt RE J Health Commun; 2007; 12(5):471-91. PubMed ID: 17710597 [TBL] [Abstract][Full Text] [Related]
2. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003. Cowden AL; Katz KA Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900 [TBL] [Abstract][Full Text] [Related]
3. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications. Kopp SW; Bang HK Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219 [TBL] [Abstract][Full Text] [Related]
4. [An analysis of the pharmaceuticals market in Vietnam]. Simonet D Sante; 2001; 11(3):155-60. PubMed ID: 11641078 [TBL] [Abstract][Full Text] [Related]
5. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970. Tobbell DA Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387 [TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical websites and the communication of risk information. Davis JJ; Cross E; Crowley J J Health Commun; 2007; 12(1):29-39. PubMed ID: 17365347 [TBL] [Abstract][Full Text] [Related]
7. Regulating pharmaceutical advertising: what will work? Shapiro MF CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416 [TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical companies as a source of health information: a pilot study of the effects of source, web site interactivity, and involvement. Kim H Health Mark Q; 2011 Jan; 28(1):57-85. PubMed ID: 21347942 [TBL] [Abstract][Full Text] [Related]
11. Bringing the FDA's Information to Market. Woloshin S; Schwartz LM Arch Intern Med; 2009 Nov; 169(21):1985-7. PubMed ID: 19933960 [No Abstract] [Full Text] [Related]
12. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers. Fleuranceau-Morel P Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550 [TBL] [Abstract][Full Text] [Related]
13. Communication about results of comparative effectiveness studies: a pharmaceutical industry view. Perfetto EM; Bailey JE; Gans-Brangs KR; Romano SJ; Rosenthal NR; Willke RJ Health Aff (Millwood); 2012 Oct; 31(10):2213-9. PubMed ID: 23048099 [TBL] [Abstract][Full Text] [Related]
14. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy. Mintzes B; Barer M; Lexchin J; Bassett KL Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480 [TBL] [Abstract][Full Text] [Related]
15. Academic perspectives on the United States Food and Drug Administration's guidance for industry on diabetes mellitus. Hennekens CH; Hebert PR; Schneider WR; O'Brien P; Demets D; Borer JS Contemp Clin Trials; 2010 Sep; 31(5):411-3. PubMed ID: 20601161 [TBL] [Abstract][Full Text] [Related]
16. Direct-to-consumer advertising--strengthening our health care system. Holmer AF N Engl J Med; 2002 Feb; 346(7):526-8. PubMed ID: 11844858 [No Abstract] [Full Text] [Related]
17. Direct-to-consumer advertising--education or emotion promotion? Wolfe SM N Engl J Med; 2002 Feb; 346(7):524-6. PubMed ID: 11844857 [No Abstract] [Full Text] [Related]
18. To inform or persuade? Direct-to-consumer advertising of prescription drugs. Berndt ER N Engl J Med; 2005 Jan; 352(4):325-8. PubMed ID: 15673797 [No Abstract] [Full Text] [Related]
19. Perestroika in pharma: evolution or revolution in drug development? FitzGerald GA Mt Sinai J Med; 2010; 77(4):327-32. PubMed ID: 20687177 [TBL] [Abstract][Full Text] [Related]
20. Consumer perceptions of prescription drug websites: a pilot study. Wymer W Health Mark Q; 2010 Apr; 27(2):173-94. PubMed ID: 20446140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]